We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
Cap. Flow
-$59.5M
Cap. Flow %
-0.14%
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 16.4%
2 Technology 15.29%
3 Healthcare 13.69%
4 Industrials 10.84%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPNS
2951
DELISTED
Sapiens International
SPNS
-26,346
Closed -$339K
TDW icon
2952
Tidewater
TDW
$3.6B
-2,925
Closed -$108K
TLPH icon
2953
Talphera
TLPH
$67.5M
-1,889
Closed -$119K
TNDM icon
2954
Tandem Diabetes Care
TNDM
$1.23B
-1,636
Closed -$20K
TOVX icon
2955
Theriva Biologics
TOVX
$9.5M
-11
Closed -$59K
TPST icon
2956
Tempest Therapeutics
TPST
$14M
-10
Closed -$56K
TTNP
2957
DELISTED
Titan Pharmaceuticals
TTNP
-6
Closed -$69K
UONEK icon
2958
Urban One Class D
UONEK
$22.6M
-1,275
Closed -$42K
VANI icon
2959
Vivani Medical
VANI
$112M
-458
Closed -$13K
VNCE icon
2960
Vince Holding Corp
VNCE
$79.8M
-2,443
Closed -$38K
NAGE
2961
Niagen Bioscience
NAGE
$252M
-53,053
Closed -$143K
AY
2962
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
-70,249
Closed -$1.47M
ASXC
2963
DELISTED
Asensus Surgical, Inc.
ASXC
-4,618
Closed -$73K
AVGR
2964
DELISTED
Avinger, Inc. Common Stock
AVGR
0
-$24K
TTOO
2965
DELISTED
T2 Biosystems, Inc
TTOO
-3
Closed -$75K
BPTH
2966
DELISTED
Bio-Path Holdings Inc
BPTH
-25
Closed -$84K
MRTX
2967
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-16,954
Closed -$88K
INFI
2968
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-65,077
Closed -$210K
ISEE
2969
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-36,440
Closed -$133K
SRNE
2970
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-34,686
Closed -$137K
AGTC
2971
DELISTED
Applied Genetic Technologies Corporation
AGTC
-14,235
Closed -$98K
MN
2972
DELISTED
MANNING & NAPIER, INC.
MN
-12,108
Closed -$69K
AMPE
2973
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-121
Closed -$29K
USAK
2974
DELISTED
USA Truck Inc
USAK
-10,562
Closed -$78K
ALJJ
2975
DELISTED
ALJ Regional Holdings Inc
ALJJ
-18,979
Closed -$71K

Similar funds

RhumbLine Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
  • RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
  • RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
  • RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
  • RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
  • RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.